Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial

Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page footer. This change does not affect the study details, eligibility criteria, outcomes, or any user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:09:07.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer updates add Revision: v3.3.3 and remove HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:00:10.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The site revision label in the footer updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T10:42:29.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removed the general operating-status notice about government funding. This does not affect the study details, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:52:34.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Two screenshots show the same Study Details page with identical content and layout; no changes were detected.
    Difference
    0.4%
    Check dated 2025-11-03T20:43:21.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    4%
    Check dated 2025-10-06T04:56:03.000Z thumbnail image

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.